Huppert Doreen, Grill Eva, Brandt Thomas
Institute for Clinical Neurosciences, German Center for Vertigo and Balance Disorders, Ludwig-Maximilians-University Munich, Munich, Germany.
Institute for Medical Information Processing, Biometrics and Epidemiology, Ludwig-Maximilians-University Munich, Munich, Germany.
Front Neurol. 2017 Jun 1;8:211. doi: 10.3389/fneur.2017.00211. eCollection 2017.
To construct and validate a short scale for the assessment of the severity of visual height intolerance (vHI) and acrophobia.
The questionnaire was developed from two earlier representative epidemiological studies ( = 5,529). Items were applied in a telephone survey of a representative population-based sample.
A total of 1,960 persons were included. The life-time prevalence of vHI was 32.7% (f: 36.1%; m: 28.4%); 12% of these persons fulfilled the psychiatric criteria of acrophobia. Rasch analysis of 11 items on severity, symptoms, and triggers resulted in an 8-item scale with good fit to the model. The score differentiated well between persons with and without acrophobia. The distribution of the scores on the metric scale of the questionnaires of those individuals with acrophobia is separate and distinct from that of susceptibles without acrophobia, although there is some overlap.
Our proposed short questionnaire (vHISS, see Table 1 and Supplementary Material) allows a continuous quantification of the severity of vHI within a metric interval scale from 0 to 13. The diagnosis of acrophobia can be established by including two additional questions.
构建并验证一个用于评估视觉恐高症(vHI)和恐高症严重程度的简短量表。
该问卷基于两项早期具有代表性的流行病学研究(n = 5529)编制而成。这些条目应用于对一个具有代表性的基于人群的样本的电话调查中。
共纳入1960人。vHI的终生患病率为32.7%(女性:36.1%;男性:28.4%);其中12%的人符合恐高症的精神病学标准。对11个关于严重程度、症状和触发因素的条目进行拉施分析,得出一个8条目量表,该量表与模型拟合良好。该分数在有恐高症和无恐高症的人之间有很好的区分度。尽管存在一些重叠,但恐高症患者问卷的度量量表上的分数分布与无恐高症的易患人群的分数分布是分开且不同的。
我们提出的心问卷(vHISS,见表1和补充材料)能够在0至13的度量区间量表内对vHI的严重程度进行连续量化。通过增加两个额外问题可以确立恐高症的诊断。